What "insurance laws" "subsidize" drug costs?
The cost of regulatory approval is high, but that's justified because the economic cost of a bad or even just ineffective drug piles up very quickly. Reduce the life expectancy of 1,000 people by 10 years (or give them an ineffective alternative to a drug that could extend their life by 10 years) and that's a billion dollars of damages right there. Is there a cheaper solution than extensive clinical trials that accomplished the same result?
It's not clear there is. Remember, what really makes approval so expensive is that most candidate drugs don't get approval. So the investment into all the drugs that don't work has to be recouped from the ones that do. But the fact that so many drugs fail at the clinic trial stage suggests we don't have better ways of predicting whether drugs will be safe and effective. Drug companies don't invest into drugs that don't pass approval for funsies. If they could determine a drug wasn't going to pass approval before the clinical trials, they'd do it. It'd be pure profit for them. Also, the fact that so many drugs don't pass approval suggests that the FDA is keeping a bunch of ineffective and harmful drugs off the market. The cost of getting rid of the FDA has to account for the cost of those bad and ineffective drugs.
Also, getting rid of these things would not make the drug industry a "free market." In any advanced society, the government will pay for drugs for elderly and poor people. That creates an entity that can exercise monopsony power. Get rid of patents on drugs, then you get the free rider effect undermining R&D. And get rid of the FDA, and you end up with a market with huge information asymmetries that allow drug manufacturers to sell products that don't work without customers having a way to know that. These would destroy any hope of a functioning competitive market. You can't talk about markets while pretending only the parts of economics that comport with your world view exist.
I wonder what the result would be of vastly reducing regulatory approval requirements, but in exchange giving pharmaceutical companies unlimited liability. So, sure, put that poorly-tested drug out there, but every person who has horrifying side-effects is going to sue you for millions
I don't think lawsuits are the best "first line of defense" for protecting consumers against harmful drugs. Because the usual measure of damages is the cost of harm, the actual recovery (once discounted by litigation risk and diminished by legal fees), is a fraction of the cost of the harm. That discount is particularly significant in medical cases, because proving causation is very difficult (how do you know that this drug caused your dad's heart attack instead of the three others he was taking?).
Moreover, drug-related litigation these days relies heavily on the factual record developed by clinical trials and FDA investigations. Class action lawsuits are often precipitated by an FDA action. E.g. major litigation like Fen-Phen and Vioxx, that netted tens of billions of dollars in recovery for consumers, were kicked off by FDA recalls. Individual litigants are poorly positioned to develop the scientific record necessary to support a lawsuit.
Perhaps an advanced society should involve one generation taking care of the next instead of the government?
Not really. Indeed, given voting patterns it's more like the older generation empowers enforcers to rob the younger generation and then empowers others to use those stolen funds to buy them drugs.
On the other hand if I had less money I might be more willing to take risks. Thus, regulation is not an independent thing and depends on the economy it's operating in.
PS: Historically milk was surprisingly deadly. Without regulation it would likely be much safer than that today, but not as safe as it currently is.
As to having a personal relationship with a farmer, I grew up next to a farm. It's very much an industrial process.
Assuming you don't find fault with the mere concept of patents, I am legitimately curious why patenting a molecule shouldn't also be possible.
And even if you don't buy that argument (it's admittedly tenuous) the fact that it's a discovery wouldn't convince me that the discoverer shouldn't still get exclusivity rights, given the amount of research involved in discovering new molecules and shepherding them through the approval process.
Could you possibly find something a little less conspiracy theory looking? Also something a little less manifesto.
Clearly his own blog.
if you think finding out which molecule fights cancer cells vs kills you outright and how to produce it in controlled fashion is trivial, you're a moron.
if you think creating genetically enginnered bacteria to produce insulin is trivial, you're an utter moron. lest you like injecting harvested insulin from pigs or dead humans.
HN likes to pride itself on techie knowledge, but the cluelessness around actual hard tech is staggering. modern medicine is up there with rocket science, worthy of nobel prizes.
they just CURED hep C for FUCKS SAKE. but yeah, no reward for that, but sharing catpics - here, have billions.
There are many other fields with very high barriers to entry and which require very large R&D budgets, but which - unlike the prescription drug market - nonetheless manage to attract competitiors: The semiconductor industry, for example, comes to mind.
pharma is full of competitors. exactly because it rewards risk. the whole point of the system. and the patent cliff hits and generics and biosimilars take over.
You patent the method of synthesis or extraction, and you patent the method for treating a human disease or ailment.
If you discovered a novel use for acetylsalicylic acid (aspirin), you could patent that. You are not re-patenting aspirin. It can still be used as an analgesic.
If you discovered a novel process to produce ethanol, you could patent that. You are not re-patenting alcohol. People could still use the traditional fermentation and distillation process. You could even patent a process step to remove the remaining water from azeotropic distilled alcohol.
Obviously, such patents are more monetizable if the molecule in question is expensive to produce by the public domain processes, has no other commonly known uses, or is a controlled substance.
So in order for me to accept a patent on a molecule, it would have to be found nowhere else in nature or in prior art, and the applicant must have synthesized a measurable quantity of it.
In practice, this means patentable molecules have to be rather complex, because there are a ridiculous number of compounds that have been created once, for someone's dissertation, or to create catalog entries for boiling points, freezing points, dissociation constants, and such, and then never looked at again.
Quite a lot of "new" drugs were actually first described decades ago and then shelved. There are just too many possibilities in organic chemistry to examine each in detail without a specific application already in mind.
IMO, at a minimum it should have much stronger warning labels on it.
Obama played a big role in banning this type of imports. Just saying. And TPP/TTIP would make this problem much worse, and virtually irreversible, because then they can just say "well, we wish we could change the monopoly laws now, but it's in the treaty, you see...so tough luck."
The FDA needs to be shut down. Perhaps replaced with something like a prediction market, where people can bet on how likely a drug is to pass a trial or even work in specific patients.
Not entirely true: there's adrenaclick. But if a doctor writes "epipen", the pharmacist isn't allowed to give you an adrenaclick, even though that kind of substitution is usually allowed. http://slatestarcodex.com/2016/08/29/reverse-voxsplaining-dr...
I've heard that the approvals process eats up almost half of those years. (Or if not the approvals process, then something that's going on after they get the patent but before they're allowed to sell it.)
Edited to add: Also, people often lump the market exclusivity extensions in with the patent. The FDA offers companies and incentive to try their drugs in children. Without this, almost nothing would be approved for kids because the trials are ridiculously expensive (even compared to adult trials).
And yet, IIRC, pharmaceutical companies spend about 20% of their revenues on research, but about 40% or more on marketing. These costs are galaxonomical!
Assuming one's health has an even higher threshold, and that a pharma company can't exactly cold email everyone in the U.S, well... That's a lot of commercials to get the word out. That's 800,000+ doctors to educate on a new option..
Marketing always goes hand in hand with product development.
I'd rather have a pharma company that's still in business charging $30,000/mo for a solution vs a company that charged the minimum, and thus has thrown away any chances of making successful products in the future.
* Ridiculously long patent validity periods. Let's put aside the fact that patenting a fucking molecule is even a thing, 20+ years is way too long a term to guarantee profit to a private corporation. Enforced by governments.
* Heavily subsidized (read: price artificially propped up) by insurance laws. This is student loans all over again. Again, created by governments.
* Astronomically high R&D costs, most of which is the cost of obtaining regulatory approval. Enforced by government agencies.
Free market? Yeah, right.